HIVgP160 Vaccine

**Semantic type:** Immunologic Factor|Pharmacologic Substance

**Definition:** A synthetic HIV vaccine based on a recombinant canary pox virus vector expressing the human immunodeficiency virus (HIV) glycoprotein gp160. HIVgP160 vaccine has been used to generate in vivo primary T lymphocyte response against HIV antigens. (NCI04)